000 01655 a2200445 4500
005 20250515152521.0
264 0 _c20090122
008 200901s 0 0 eng d
022 _a1469-2147
024 7 _a10.1017/S0963180108090026
_2doi
040 _aNLM
_beng
_cNLM
245 0 0 _aFrom the editors.
_h[electronic resource]
260 _bCambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees
_c2009
300 _a4-5 p.
_bdigital
500 _aPublication Type: Editorial; Introductory Journal Article
650 0 4 _aBlack or African American
_xgenetics
650 0 4 _aAnalgesia
_xethics
650 0 4 _aBioethical Issues
650 0 4 _aBioethics
650 0 4 _aConscience
650 0 4 _aDrug Combinations
650 0 4 _aEthics, Clinical
650 0 4 _aHeart Failure
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aHydralazine
_xtherapeutic use
650 0 4 _aInterdisciplinary Communication
650 0 4 _aIsosorbide Dinitrate
_xtherapeutic use
650 0 4 _aLiver Diseases, Alcoholic
_xsurgery
650 0 4 _aLiver Transplantation
_xethics
650 0 4 _aMorals
650 0 4 _aNeurosciences
_xethics
650 0 4 _aPatient-Centered Care
_xethics
650 0 4 _aPersistent Vegetative State
650 0 4 _aSocial Sciences
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
650 0 4 _aWaiting Lists
773 0 _tCambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees
_gvol. 18
_gno. 1
_gp. 4-5
856 4 0 _uhttps://doi.org/10.1017/S0963180108090026
_zAvailable from publisher's website
999 _c18542744
_d18542744